Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Azopharma Expands cGMP CTM Manufacturing Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Azopharma Expands cGMP CTM Manufacturing Capacity

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Azopharma has reached an agreement to purchase Kos Pharmaceuticals’ R&D facility along with assets in Hollywood, FL. Azopharma chief executive officer Phil Meeks said, “We are pleased about the addition of our new facility in Hollywood, FL, and our expanded capacity to manufacture cGMP clinical trial material. This acquisition will significantly increase our ability to support our customers and our Phase I Express process, which enables our customers to move quickly and efficiently toward clinical trials. Phase I Express includes preclinical, preformulation, formulation development, analytical R&D, QC release, stability, manufacturing, packaging and labeling of clinical supplies for Phase I, studies.”

The FL facilities are cGMP compliant and FDA registered and inspected, as well as DEA approved for testing all schedules of controlled drugs and for manufacture on an as-requested basis.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics